Pan, Changyu

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., et al. (2017) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 323

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

for the ADVANCE Collaborative group, de Galan, B. E., Zoungas, S., Chalmers, J., Anderson, C., Dufouil, C., Pillai, A., Cooper, M., Grobbee, D. E., Hackett, M., et al. (2009) · Diabetologia

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 243

Pituitary Stalk Interruption Syndrome in Chinese People: Clinical Characteristic Analysis of 55 Cases

Guo, Q., Yang, Y., Mu, Y., Lu, J., Pan, C., Dou, J., Lv, Z., Ba, J., Wang, B., Zou, X., et al. (2013) · PLoS ONE

Pituitary Gland Disorders and TreatmentsHypothalamic control of reproductive hormones

Cited by 57

Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study

Zhou, X., Ji, L., Ran, X., Su, B., Ji, Q., Pan, C., Weng, J., Ma, C., Hao, C., Zhang, D., et al. (2016) · PLOS ONE

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 56

Relationship between healthy lifestyle behaviors and cardiovascular risk factors in Chinese patients with type 2 diabetes mellitus: a subanalysis of the CCMR-3B STUDY

on behalf of CCMR-3B STUDY Investigators, Huang, Y., Li, J., Zhu, X., Sun, J., Ji, L., Hu, D., Pan, C., Tan, W., Jiang, S., et al. (2017) · Acta Diabetologica

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk Factors

Cited by 21

Comparative effectiveness and safety of different basal insulins in a real-world setting

Ji, L., Zhang, P., Zhu, D., Lu, J., Guo, X., Wu, Y., Li, X., Ji, J., Jia, W., Yang, W., et al. (2017) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 13